Helius Medical Technologies (NASDAQ:HSDT) and QT Imaging (NASDAQ:QTI) Head-To-Head Review

Helius Medical Technologies (NASDAQ:HSDT) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk and valuation.

Volatility and Risk

Helius Medical Technologies has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.13, indicating that its share price is 113% less volatile than the S&P 500.

Valuation & Earnings

This table compares Helius Medical Technologies and QT Imaging’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Helius Medical Technologies	$640,000.00	4.72	-$8.85 million	($13.04)	-0.08
QT Imaging	N/A	N/A	-$4.03 million	N/A	N/A

QT Imaging has lower revenue, but higher earnings than Helius Medical Technologies.

Profitability

This table compares Helius Medical Technologies and QT Imaging’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Helius Medical Technologies	-1,328.14%	-297.49%	-107.36%
QT Imaging	N/A	N/A	-19.75%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Helius Medical Technologies and QT Imaging, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Helius Medical Technologies	0	0	1	0	3.00
QT Imaging	0	0	0	0	N/A

Helius Medical Technologies currently has a consensus target price of $24.00, suggesting a potential upside of 2,252.94%. Given Helius Medical Technologies’ higher possible upside, analysts clearly believe Helius Medical Technologies is more favorable than QT Imaging.

Institutional & Insider Ownership

18.6% of Helius Medical Technologies shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 5.1% of Helius Medical Technologies shares are held by insiders. Comparatively, 75.4% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

QT Imaging beats Helius Medical Technologies on 6 of the 10 factors compared between the two stocks.

About Helius Medical Technologies

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.